Treatment of patients with chronic hepatitis C with normal liver enzymes

Saudi Medical Journal

Volumn 23, Issue 3, 2002, Pages 301-304

  Akbar, Hisham O ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Branched deoxyribonucleic acid signal amplification test; End of treatment response; Hepatitis C virus antibody; Polymerase chain reaction; Sustained virological response

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DNA; HEPATITIS C ANTIBODY; LIVER ENZYME; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PROSPECTIVE STUDY; SAUDI ARABIA; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN; VIRAL LOAD;

EID: 0036219249     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Therapy of hepatitis C patients with normal aminotransferase levels
2. Epidemiology of hepatitis C in the West
3. Volunteer blood donors with antibodies to hepatitis C virus: Clinical, biochemical, virologic, and histologic features
4. Over view of viral hepatitis A through TT virus
5. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
6. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
7. Clinical, histological, and virological features of hepatitis C virus carrier with persistently normal or abnormal alanine transaminases levels
8. Hepatitis C virus carriers with normal ALT activity: Viremia, genotype and effect of interferon therapy
9. Poor efficacy of alpha Interferon treatment in patients affected by chornic hepatitis C with normal or near ALT levels
10. Interferon-alpha 2b therapy in low-activity hepatitis C: A pilot study
11. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis
12. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study
13. Interferon alpha therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity
14. Interferon - A therapy for individuals with normal serum alanine aminotransferase levels before treatment
15. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near normal alanine aminotransferase levels
16. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase level
17. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities
18. Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors
19. The virological and histological states of antihepatitis C virus positive subjects with normal liver biochemical values